Skip to main content

Table 2 Comparison of the expression of 5-LOX, COX-1, COX-2 and \(\hbox {CysLT}_2\) between the respiratory epithelium, the submucosal glands and the squamous epithelium

From: Expression of COX-1, COX-2, 5-LOX and \(\hbox {CysLT}_2\) in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease

 

RE; mean (SE)

SG mean (SE)

SEP mean (SE)

p-value RE vs. SG

p-value SEP vs. SG

p-value RE vs. SEP

5-LOX nasal polyps

9.645 (1.197)

13.588 (1.241)

9.42 (1.59)

0.038

0.094

NS

5-LOX bronchial tissue

7.266 (1.458)

15.901 (1.778)

6.915 (1.516)

0.001

0.001

NS

COX-1 nasal polyps

13.287 (1.82)

10.24 (1.42)

13.784 (1.774)

0.001

0.003

NS

COX-1 bronchial tissue

10.611 (1.912)

5.103 (1.959)

11.83 (2.077)

0.028

0.003

NS

COX-2- nasal polyps

21.245 (1.335)

13.763 (0.978)

20.959 (1.494)

< 0.001

< 0.001

NS

COX-2 bronchial tissue

14.47 (1.898)

7.406 (1.581)

13.794 (1.947)

0.002

0.011

NS

\(\hbox {CysLT}_2\) nasal polyps

3.041 (0.895)

18.851 (1.125)

3.078 (0.895)

< 0.001

< 0.001

NS

\(\hbox {CysLT}_2\) bronchial tissue

1.938 (0.851)

13.969 (1.841)

1.936 (0.581)

< 0.001

< 0.001

NS

  1. General comparison of the mean immunoreactive score (IRS) of the respiratory epithelium (RE), submucosal glands (SG) and squamous epithelium (SEP), irrespective of the patients’ groups, using the mixed linear statistical model. Mean IRS are indicated +/− standard error (SE). NS nonsignificant